Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nateglinide (Senaglinide) is an oral hypoglycemic agent and amino acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Nateglinide has been linked to rare instances of clinically apparent acute liver injury.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 41.00 | |
25 mg | In stock | $ 83.00 | |
50 mg | In stock | $ 148.00 | |
100 mg | In stock | $ 249.00 | |
200 mg | In stock | $ 359.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 58.00 |
Description | Nateglinide (Senaglinide) is an oral hypoglycemic agent and amino acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Nateglinide has been linked to rare instances of clinically apparent acute liver injury. |
Synonyms | A4166, Senaglinide |
Molecular Weight | 317.42 |
Formula | C19H27NO3 |
CAS No. | 105816-04-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 31.7 mg/mL (100 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Nateglinide 105816-04-4 DNA Damage/DNA Repair Membrane transporter/Ion channel Metabolism Proteases/Proteasome Ubiquitination PPAR Potassium Channel Proteasome insulin β-cell DPP inhibit A 4166 A-4166 Inhibitor A4166 KcsA Dipeptidyl Peptidase Senaglinide diabetes short-acting glucose inhibitor